Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Neha Panjwani

Amgen Stock: Is AMGN Outperforming the Healthcare Sector?

Amgen Inc. (AMGN), headquartered in Thousand Oaks, California, discovers, develops, manufactures, and delivers human therapeutics. With a market cap of $165.5 billion, the company focuses on human therapeutics and concentrates on innovating novel medicines based on cellular and molecular biology.

Companies worth $10 billion or more are generally described as “large-cap stocks,” and AMGN perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the general drug manufacturers industry. AMGN has a diverse and innovative product portfolio, including blockbuster drugs like Prolia, ENBREL, and XGEVA. Amgen's robust pipeline features potential first-in-class medicines. With operations worldwide, Amgen has established a strong market presence and international sales growth, diversifying revenue and mitigating market-specific risks. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.